APO Research
Talk to an analyst

APO RESEARCH · REPORT

Clotting Factors Ⅷ

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Clotting Factors Ⅷ Market Analysis and Forecast 2026-2032

23 December 2025199 pages

Choose your research edition.

Industry ResearchClotting Factors Ⅷ Industry Research Report 2026110 pages · $2,950 USDIndustry Growth & TrendsGlobal Clotting Factors Ⅷ Industry Growth and Trends Forecast to 203274 pages · $3,450 USDMarket StructureGlobal Clotting Factors Ⅷ Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032175 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Clotting Factors Ⅷ Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Clotting Factors Ⅷ Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global Clotting Factors Ⅷ market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Clotting Factors Ⅷ is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Clotting Factors Ⅷ is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Clotting Factors Ⅷ is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Clotting Factors Ⅷ is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Clotting Factors Ⅷ include Taibang Biological, Shanghai Laishi, Lvshizi and Hualan Biological, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Clotting Factors Ⅷ, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Clotting Factors Ⅷ, also provides the sales of main regions and countries. Of the upcoming market potential for Clotting Factors Ⅷ, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Clotting Factors Ⅷ sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Clotting Factors Ⅷ market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Clotting Factors Ⅷ sales, projected growth trends, production technology, application and end-user industry.

Clotting Factors Ⅷ Segment by Company

Taibang Biological

Shanghai Laishi

Lvshizi

Hualan Biological

Clotting Factors Ⅷ Segment by Type

Injection

Freeze-dried Injection

Clotting Factors Ⅷ Segment by Application

Hemophilia A

Bleeding Diseases

Clotting Factors Ⅷ Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Clotting Factors Ⅷ market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Clotting Factors Ⅷ and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Clotting Factors Ⅷ.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Clotting Factors Ⅷ in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Clotting Factors Ⅷ manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Clotting Factors Ⅷ sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Clotting Factors Ⅷ Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Injection Major Manufacturers Table 3. Freeze-dried Injection Major Manufacturers Table 4. Global Clotting Factors Ⅷ Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Hemophilia A Major Manufacturers Table 6. Bleeding Diseases Major Manufacturers Table 7. Clotting Factors Ⅷ Industry Trends Table 8. Clotting Factors Ⅷ Industry Drivers Table 9. Clotting Factors Ⅷ Industry Opportunities and Challenges Table 10. Clotting Factors Ⅷ Industry Restraints Table 11. Global Clotting Factors Ⅷ Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 12. Global Clotting Factors Ⅷ Revenue by Region (2021-2026) & (US$ Million) Table 13. Global Clotting Factors Ⅷ Revenue by Region (2027-2032) & (US$ Million) Table 14. Global Clotting Factors Ⅷ Revenue Market Share by Region (2021-2026) Table 15. Global Clotting Factors Ⅷ Revenue Market Share by Region (2027-2032) Table 16. Global Clotting Factors Ⅷ Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (k units) Table 17. Global Clotting Factors Ⅷ Sales by Region (2021-2026) & (k units) Table 18. Global Clotting Factors Ⅷ Sales by Region (2027-2032) & (k units) Table 19. Global Clotting Factors Ⅷ Sales Market Share by Region (2021-2026) Table 20. Global Clotting Factors Ⅷ Sales Market Share by Region (2027-2032) Table 21. Global Clotting Factors Ⅷ Revenue by Manufacturers (US$ Million) & (2021-2026) Table 22. Global Clotting Factors Ⅷ Revenue Market Share by Manufacturers (2021-2026) Table 23. Global Clotting Factors Ⅷ Sales by Manufacturers (US$ Million) & (2021-2026) Table 24. Global Clotting Factors Ⅷ Sales Market Share by Manufacturers (2021-2026) Table 25. Global Clotting Factors Ⅷ Sales Price (US$/unit) of Manufacturers (2021-2026) Table 26. Global Clotting Factors Ⅷ Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 27. Global Clotting Factors Ⅷ Key Manufacturers Manufacturing Sites & Headquarters Table 28. Global Clotting Factors Ⅷ Manufacturers, Product Type & Application Table 29. Global Clotting Factors Ⅷ Manufacturers' Establishment Date Table 30. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 31. Global Clotting Factors Ⅷ by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 32. Global Clotting Factors Ⅷ Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Clotting Factors Ⅷ Revenue by Type (2021-2026) & (US$ Million) Table 34. Global Clotting Factors Ⅷ Revenue by Type (2027-2032) & (US$ Million) Table 35. Global Clotting Factors Ⅷ Revenue Market Share by Type (2021-2026) Table 36. Global Clotting Factors Ⅷ Revenue Market Share by Type (2027-2032) Table 37. Global Clotting Factors Ⅷ Sales by Type 2021 VS 2025 VS 2032 (k units) Table 38. Global Clotting Factors Ⅷ Sales by Type (2021-2026) & (k units) Table 39. Global Clotting Factors Ⅷ Sales by Type (2027-2032) & (k units) Table 40. Global Clotting Factors Ⅷ Sales Market Share by Type (2021-2026) Table 41. Global Clotting Factors Ⅷ Sales Market Share by Type (2027-2032) Table 42. Global Clotting Factors Ⅷ Price by Type (2021-2026) & (US$/unit) Table 43. Global Clotting Factors Ⅷ Price by Type (2027-2032) & (US$/unit) Table 44. Global Clotting Factors Ⅷ Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 45. Global Clotting Factors Ⅷ Revenue by Application (2021-2026) & (US$ Million) Table 46. Global Clotting Factors Ⅷ Revenue by Application (2027-2032) & (US$ Million) Table 47. Global Clotting Factors Ⅷ Revenue Market Share by Application (2021-2026) Table 48. Global Clotting Factors Ⅷ Revenue Market Share by Application (2027-2032) Table 49. Global Clotting Factors Ⅷ Sales by Application 2021 VS 2025 VS 2032 (k units) Table 50. Global Clotting Factors Ⅷ Sales by Application (2021-2026) & (k units) Table 51. Global Clotting Factors Ⅷ Sales by Application (2027-2032) & (k units) Table 52. Global Clotting Factors Ⅷ Sales Market Share by Application (2021-2026) Table 53. Global Clotting Factors Ⅷ Sales Market Share by Application (2027-2032) Table 54. Global Clotting Factors Ⅷ Price by Application (2021-2026) & (US$/unit) Table 55. Global Clotting Factors Ⅷ Price by Application (2027-2032) & (US$/unit) Table 56. Taibang Biological Company Information Table 57. Taibang Biological Business Overview Table 58. Taibang Biological Clotting Factors Ⅷ Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 59. Taibang Biological Clotting Factors Ⅷ Product Portfolio Table 60. Taibang Biological Recent Development Table 61. Shanghai Laishi Company Information Table 62. Shanghai Laishi Business Overview Table 63. Shanghai Laishi Clotting Factors Ⅷ Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 64. Shanghai Laishi Clotting Factors Ⅷ Product Portfolio Table 65. Shanghai Laishi Recent Development Table 66. Lvshizi Company Information Table 67. Lvshizi Business Overview Table 68. Lvshizi Clotting Factors Ⅷ Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 69. Lvshizi Clotting Factors Ⅷ Product Portfolio Table 70. Lvshizi Recent Development Table 71. Hualan Biological Company Information Table 72. Hualan Biological Business Overview Table 73. Hualan Biological Clotting Factors Ⅷ Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 74. Hualan Biological Clotting Factors Ⅷ Product Portfolio Table 75. Hualan Biological Recent Development Table 76. North America Clotting Factors Ⅷ Revenue by Type (2021-2026) & (US$ Million) Table 77. North America Clotting Factors Ⅷ Revenue by Type (2027-2032) & (US$ Million) Table 78. North America Clotting Factors Ⅷ Sales by Type (2021-2026) & (k units) Table 79. North America Clotting Factors Ⅷ Sales by Type (2027-2032) & (k units) Table 80. North America Clotting Factors Ⅷ Sales Price by Type (2021-2026) & (US$/unit) Table 81. North America Clotting Factors Ⅷ Sales Price by Type (2027-2032) & (US$/unit) Table 82. North America Clotting Factors Ⅷ Revenue by Application (2021-2026) & (US$ Million) Table 83. North America Clotting Factors Ⅷ Revenue by Application (2027-2032) & (US$ Million) Table 84. North America Clotting Factors Ⅷ Sales by Application (2021-2026) & (k units) Table 85. North America Clotting Factors Ⅷ Sales by Application (2027-2032) & (k units) Table 86. North America Clotting Factors Ⅷ Sales Price by Application (2021-2026) & (US$/unit) Table 87. North America Clotting Factors Ⅷ Sales Price by Application (2027-2032) & (US$/unit) Table 88. North America Clotting Factors Ⅷ Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 89. North America Clotting Factors Ⅷ Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 90. North America Clotting Factors Ⅷ Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 91. North America Clotting Factors Ⅷ Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 92. North America Clotting Factors Ⅷ Sales by Country (2021-2026) & (k units) Table 93. North America Clotting Factors Ⅷ Sales by Country (2027-2032) & (k units) Table 94. North America Clotting Factors Ⅷ Sales Price by Country (2021-2026) & (US$/unit) Table 95. North America Clotting Factors Ⅷ Sales Price by Country (2027-2032) & (US$/unit) Table 96. United States Clotting Factors Ⅷ Revenue (2021-2032) & (US$ Million) Table 97. Canada Clotting Factors Ⅷ Revenue (2021-2032) & (US$ Million) Table 98. Mexico Clotting Factors Ⅷ Revenue (2021-2032) & (US$ Million) Table 99. Europe Clotting Factors Ⅷ Revenue by Type (2021-2026) & (US$ Million) Table 100. Europe Clotting Factors Ⅷ Revenue by Type (2027-2032) & (US$ Million) Table 101. Europe Clotting Factors Ⅷ Sales by Type (2021-2026) & (k units) Table 102. Europe Clotting Factors Ⅷ Sales by Type (2027-2032) & (k units) Table 103. Europe Clotting Factors Ⅷ Sales Price by Type (2021-2026) & (US$/unit) Table 104. Europe Clotting Factors Ⅷ Sales Price by Type (2027-2032) & (US$/unit) Table 105. Europe Clotting Factors Ⅷ Revenue by Application (2021-2026) & (US$ Million) Table 106. Europe Clotting Factors Ⅷ Revenue by Application (2027-2032) & (US$ Million) Table 107. Europe Clotting Factors Ⅷ Sales by Application (2021-2026) & (k units) Table 108. Europe Clotting Factors Ⅷ Sales by Application (2027-2032) & (k units) Table 109. Europe Clotting Factors Ⅷ Sales Price by Application (2021-2026) & (US$/unit) Table 110. Europe Clotting Factors Ⅷ Sales Price by Application (2027-2032) & (US$/unit) Table 111. Europe Clotting Factors Ⅷ Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 112. Europe Clotting Factors Ⅷ Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 113. Europe Clotting Factors Ⅷ Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 114. Europe Clotting Factors Ⅷ Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 115. Europe Clotting Factors Ⅷ Sales by Country (2021-2026) & (k units) Table 116. Europe Clotting Factors Ⅷ Sales by Country (2027-2032) & (k units) Table 117. Europe Clotting Factors Ⅷ Sales Price by Country (2021-2026) & (US$/unit) Table 118. Europe Clotting Factors Ⅷ Sales Price by Country (2027-2032) & (US$/unit) Table 119. Germany Clotting Factors Ⅷ Revenue (2021-2032) & (US$ Million) Table 120. France Clotting Factors Ⅷ Revenue (2021-2032) & (US$ Million) Table 121. U.K. Clotting Factors Ⅷ Revenue (2021-2032) & (US$ Million) Table 122. Italy Clotting Factors Ⅷ Revenue (2021-2032) & (US$ Million) Table 123. Russia Clotting Factors Ⅷ Revenue (2021-2032) & (US$ Million) Table 124. Spain Clotting Factors Ⅷ Revenue (2021-2032) & (US$ Million) Table 125. Netherlands Clotting Factors Ⅷ Revenue (2021-2032) & (US$ Million) Table 126. Switzerland Clotting Factors Ⅷ Revenue (2021-2032) & (US$ Million) Table 127. Sweden Clotting Factors Ⅷ Revenue (2021-2032) & (US$ Million) Table 128. Poland Clotting Factors Ⅷ Revenue (2021-2032) & (US$ Million) Table 129. China Clotting Factors Ⅷ Revenue by Type (2021-2026) & (US$ Million) Table 130. China Clotting Factors Ⅷ Revenue by Type (2027-2032) & (US$ Million) Table 131. China Clotting Factors Ⅷ Sales by Type (2021-2026) & (k units) Table 132. China Clotting Factors Ⅷ Sales by Type (2027-2032) & (k units) Table 133. China Clotting Factors Ⅷ Sales Price by Type (2021-2026) & (US$/unit) Table 134. China Clotting Factors Ⅷ Sales Price by Type (2027-2032) & (US$/unit) Table 135. China Clotting Factors Ⅷ Revenue by Application (2021-2026) & (US$ Million) Table 136. China Clotting Factors Ⅷ Revenue by Application (2027-2032) & (US$ Million) Table 137. China Clotting Factors Ⅷ Sales by Application (2021-2026) & (k units) Table 138. China Clotting Factors Ⅷ Sales by Application (2027-2032) & (k units) Table 139. China Clotting Factors Ⅷ Sales Price by Application (2021-2026) & (US$/unit) Table 140. China Clotting Factors Ⅷ Sales Price by Application (2027-2032) & (US$/unit) Table 141. Asia Clotting Factors Ⅷ Revenue by Type (2021-2026) & (US$ Million) Table 142. Asia Clotting Factors Ⅷ Revenue by Type (2027-2032) & (US$ Million) Table 143. Asia Clotting Factors Ⅷ Sales by Type (2021-2026) & (k units) Table 144. Asia Clotting Factors Ⅷ Sales by Type (2027-2032) & (k units) Table 145. Asia Clotting Factors Ⅷ Sales Price by Type (2021-2026) & (US$/unit) Table 146. Asia Clotting Factors Ⅷ Sales Price by Type (2027-2032) & (US$/unit) Table 147. Asia Clotting Factors Ⅷ Revenue by Application (2021-2026) & (US$ Million) Table 148. Asia Clotting Factors Ⅷ Revenue by Application (2027-2032) & (US$ Million) Table 149. Asia Clotting Factors Ⅷ Sales by Application (2021-2026) & (k units) Table 150. Asia Clotting Factors Ⅷ Sales by Application (2027-2032) & (k units) Table 151. Asia Clotting Factors Ⅷ Sales Price by Application (2021-2026) & (US$/unit) Table 152. Asia Clotting Factors Ⅷ Sales Price by Application (2027-2032) & (US$/unit) Table 153. Asia Clotting Factors Ⅷ Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 154. Asia Clotting Factors Ⅷ Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 155. Asia Clotting Factors Ⅷ Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 156. Asia Clotting Factors Ⅷ Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 157. Asia Clotting Factors Ⅷ Sales by Country (2021-2026) & (k units) Table 158. Asia Clotting Factors Ⅷ Sales by Country (2027-2032) & (k units) Table 159. Asia Clotting Factors Ⅷ Sales Price by Country (2021-2026) & (US$/unit) Table 160. Asia Clotting Factors Ⅷ Sales Price by Country (2027-2032) & (US$/unit) Table 161. Japan Clotting Factors Ⅷ Revenue (2021-2032) & (US$ Million) Table 162. South Korea Clotting Factors Ⅷ Revenue (2021-2032) & (US$ Million) Table 163. India Clotting Factors Ⅷ Revenue (2021-2032) & (US$ Million) Table 164. Australia Clotting Factors Ⅷ Revenue (2021-2032) & (US$ Million) Table 165. Taiwan Clotting Factors Ⅷ Revenue (2021-2032) & (US$ Million) Table 166. Southeast Asia Clotting Factors Ⅷ Revenue (2021-2032) & (US$ Million) Table 167. SAMEA Clotting Factors Ⅷ Revenue by Type (2021-2026) & (US$ Million) Table 168. SAMEA Clotting Factors Ⅷ Revenue by Type (2027-2032) & (US$ Million) Table 169. SAMEA Clotting Factors Ⅷ Sales by Type (2021-2026) & (k units) Table 170. SAMEA Clotting Factors Ⅷ Sales by Type (2027-2032) & (k units) Table 171. SAMEA Clotting Factors Ⅷ Sales Price by Type (2021-2026) & (US$/unit) Table 172. SAMEA Clotting Factors Ⅷ Sales Price by Type (2027-2032) & (US$/unit) Table 173. SAMEA Clotting Factors Ⅷ Revenue by Application (2021-2026) & (US$ Million) Table 174. SAMEA Clotting Factors Ⅷ Revenue by Application (2027-2032) & (US$ Million) Table 175. SAMEA Clotting Factors Ⅷ Sales by Application (2021-2026) & (k units) Table 176. SAMEA Clotting Factors Ⅷ Sales by Application (2027-2032) & (k units) Table 177. SAMEA Clotting Factors Ⅷ Sales Price by Application (2021-2026) & (US$/unit) Table 178. SAMEA Clotting Factors Ⅷ Sales Price by Application (2027-2032) & (US$/unit) Table 179. SAMEA Clotting Factors Ⅷ Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 180. SAMEA Clotting Factors Ⅷ Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 181. SAMEA Clotting Factors Ⅷ Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 182. SAMEA Clotting Factors Ⅷ Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 183. SAMEA Clotting Factors Ⅷ Sales by Country (2021-2026) & (k units) Table 184. SAMEA Clotting Factors Ⅷ Sales by Country (2027-2032) & (k units) Table 185. SAMEA Clotting Factors Ⅷ Sales Price by Country (2021-2026) & (US$/unit) Table 186. SAMEA Clotting Factors Ⅷ Sales Price by Country (2027-2032) & (US$/unit) Table 187. Brazil Clotting Factors Ⅷ Revenue (2021-2032) & (US$ Million) Table 188. Argentina Clotting Factors Ⅷ Revenue (2021-2032) & (US$ Million) Table 189. Chile Clotting Factors Ⅷ Revenue (2021-2032) & (US$ Million) Table 190. Colombia Clotting Factors Ⅷ Revenue (2021-2032) & (US$ Million) Table 191. Peru Clotting Factors Ⅷ Revenue (2021-2032) & (US$ Million) Table 192. Saudi Arabia Clotting Factors Ⅷ Revenue (2021-2032) & (US$ Million) Table 193. Israel Clotting Factors Ⅷ Revenue (2021-2032) & (US$ Million) Table 194. UAE Clotting Factors Ⅷ Revenue (2021-2032) & (US$ Million) Table 195. Turkey Clotting Factors Ⅷ Revenue (2021-2032) & (US$ Million) Table 196. Iran Clotting Factors Ⅷ Revenue (2021-2032) & (US$ Million) Table 197. Egypt Clotting Factors Ⅷ Revenue (2021-2032) & (US$ Million) Table 198. Key Raw Materials Table 199. Raw Materials Key Suppliers Table 200. Clotting Factors Ⅷ Distributors List Table 201. Clotting Factors Ⅷ Customers List Table 202. Research Programs/Design for This Report Table 203. Authors List of This Report Table 204. Secondary Sources Table 205. Primary Sources List of Figures Figure 1. Clotting Factors Ⅷ Image Figure 2. Global Clotting Factors Ⅷ Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Clotting Factors Ⅷ Market Size Share 2021 VS 2025 VS 2032 Figure 4. Injection Image Figure 5. Freeze-dried Injection Image Figure 6. Global Clotting Factors Ⅷ Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Clotting Factors Ⅷ Market Size Share 2021 VS 2025 VS 2032 Figure 8. Hemophilia A Image Figure 9. Bleeding Diseases Image Figure 10. Global Clotting Factors Ⅷ Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 11. Global Clotting Factors Ⅷ Revenue (2021-2032) & (US$ Million) Figure 12. Global Clotting Factors Ⅷ Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 13. Global Clotting Factors Ⅷ Revenue Market Share by Region: 2025 Versus 2032 Figure 14. Global Clotting Factors Ⅷ Revenue Market Share by Region (2021-2032) Figure 15. Global Clotting Factors Ⅷ Sales (2021-2032) & (k units) Figure 16. Global Clotting Factors Ⅷ Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 17. Global Clotting Factors Ⅷ Sales Market Share by Region (2021-2032) Figure 18. US & Canada & Mexico Clotting Factors Ⅷ Sales YoY (2021-2032) & (k units) Figure 19. Europe Clotting Factors Ⅷ Sales YoY (2021-2032) & (k units) Figure 20. China Clotting Factors Ⅷ Sales YoY (2021-2032) & (k units) Figure 21. Asia (Excluding China) Clotting Factors Ⅷ Sales YoY (2021-2032) & (k units) Figure 22. South America, Middle East and Africa Clotting Factors Ⅷ Sales YoY (2021-2032) & (k units) Figure 23. Global Clotting Factors Ⅷ Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 24. Global Clotting Factors Ⅷ Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 25. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 26. Global Clotting Factors Ⅷ Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 27. Global Clotting Factors Ⅷ Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 28. Global Clotting Factors Ⅷ Revenue Market Share by Type (2021-2032) Figure 29. Global Clotting Factors Ⅷ Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 30. Global Clotting Factors Ⅷ Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 31. Global Clotting Factors Ⅷ Sales Market Share by Type (2021-2032) Figure 32. Global Clotting Factors Ⅷ Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 33. Global Clotting Factors Ⅷ Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 34. Global Clotting Factors Ⅷ Revenue Market Share by Application (2021-2032) Figure 35. Global Clotting Factors Ⅷ Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 36. Global Clotting Factors Ⅷ Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 37. Global Clotting Factors Ⅷ Sales Market Share by Application (2021-2032) Figure 38. North America Clotting Factors Ⅷ Revenue Share by Type (2021-2032) Figure 39. North America Clotting Factors Ⅷ Sales Share by Type (2021-2032) Figure 40. North America Clotting Factors Ⅷ Revenue Share by Application (2021-2032) Figure 41. North America Clotting Factors Ⅷ Sales Share by Application (2021-2032) Figure 42. North America Clotting Factors Ⅷ Revenue Share by Country (2021-2032) Figure 43. North America Clotting Factors Ⅷ Sales Share by Country (2021-2032) Figure 44. Europe Clotting Factors Ⅷ Revenue Share by Type (2021-2032) Figure 45. Europe Clotting Factors Ⅷ Sales Share by Type (2021-2032) Figure 46. Europe Clotting Factors Ⅷ Revenue Share by Application (2021-2032) Figure 47. Europe Clotting Factors Ⅷ Sales Share by Application (2021-2032) Figure 48. Europe Clotting Factors Ⅷ Revenue Share by Country (2021-2032) Figure 49. Europe Clotting Factors Ⅷ Sales Share by Country (2021-2032) Figure 50. China Clotting Factors Ⅷ Revenue Share by Type (2021-2032) Figure 51. China Clotting Factors Ⅷ Sales Share by Type (2021-2032) Figure 52. China Clotting Factors Ⅷ Revenue Share by Application (2021-2032) Figure 53. China Clotting Factors Ⅷ Sales Share by Application (2021-2032) Figure 54. Asia Clotting Factors Ⅷ Revenue Share by Type (2021-2032) Figure 55. Asia Clotting Factors Ⅷ Sales Share by Type (2021-2032) Figure 56. Asia Clotting Factors Ⅷ Revenue Share by Application (2021-2032) Figure 57. Asia Clotting Factors Ⅷ Sales Share by Application (2021-2032) Figure 58. Asia Clotting Factors Ⅷ Revenue Share by Country (2021-2032) Figure 59. Asia Clotting Factors Ⅷ Sales Share by Country (2021-2032) Figure 60. SAMEA Clotting Factors Ⅷ Revenue Share by Type (2021-2032) Figure 61. SAMEA Clotting Factors Ⅷ Sales Share by Type (2021-2032) Figure 62. SAMEA Clotting Factors Ⅷ Revenue Share by Application (2021-2032) Figure 63. SAMEA Clotting Factors Ⅷ Sales Share by Application (2021-2032) Figure 64. SAMEA Clotting Factors Ⅷ Revenue Share by Country (2021-2032) Figure 65. SAMEA Clotting Factors Ⅷ Sales Share by Country (2021-2032) Figure 66. Clotting Factors Ⅷ Value Chain Figure 67. Manufacturing Cost Structure Figure 68. Clotting Factors Ⅷ Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Injection
  • Freeze-dried Injection
Applications
  • Hemophilia A
  • Bleeding Diseases
Companies covered
  • Taibang Biological
  • Shanghai Laishi
  • Lvshizi
  • Hualan Biological

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Clotting Factors Ⅷ Market by Type
  3. 1.2.1 Global Clotting Factors Ⅷ Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Injection
  5. 1.2.3 Freeze-dried Injection
  6. 1.3 Clotting Factors Ⅷ Market by Application
  7. 1.3.1 Global Clotting Factors Ⅷ Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Hemophilia A
  9. 1.3.3 Bleeding Diseases
  10. 1.4 Assumptions and Limitations
  11. 1.5 Study Goals and Objectives
2 Clotting Factors Ⅷ Market Dynamics
  1. 2.1 Clotting Factors Ⅷ Industry Trends
  2. 2.2 Clotting Factors Ⅷ Industry Drivers
  3. 2.3 Clotting Factors Ⅷ Industry Opportunities and Challenges
  4. 2.4 Clotting Factors Ⅷ Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Clotting Factors Ⅷ Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Clotting Factors Ⅷ Revenue by Region
  3. 3.2.1 Global Clotting Factors Ⅷ Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Clotting Factors Ⅷ Revenue by Region (2021-2026)
  5. 3.2.3 Global Clotting Factors Ⅷ Revenue by Region (2027-2032)
  6. 3.2.4 Global Clotting Factors Ⅷ Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Clotting Factors Ⅷ Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Clotting Factors Ⅷ Sales by Region
  9. 3.4.1 Global Clotting Factors Ⅷ Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Clotting Factors Ⅷ Sales by Region (2021-2026)
  11. 3.4.3 Global Clotting Factors Ⅷ Sales by Region (2027-2032)
  12. 3.4.4 Global Clotting Factors Ⅷ Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Clotting Factors Ⅷ Revenue by Manufacturers
  2. 4.1.1 Global Clotting Factors Ⅷ Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Clotting Factors Ⅷ Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Clotting Factors Ⅷ Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Clotting Factors Ⅷ Sales by Manufacturers
  6. 4.2.1 Global Clotting Factors Ⅷ Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Clotting Factors Ⅷ Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Clotting Factors Ⅷ Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Clotting Factors Ⅷ Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Clotting Factors Ⅷ Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Clotting Factors Ⅷ Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Clotting Factors Ⅷ Manufacturers, Product Type & Application
  13. 4.7 Global Clotting Factors Ⅷ Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Clotting Factors Ⅷ Market CR5 and HHI
  16. 4.8.2 2025 Clotting Factors Ⅷ Tier 1, Tier 2, and Tier 3
5 Clotting Factors Ⅷ Market by Type
  1. 5.1 Global Clotting Factors Ⅷ Revenue by Type
  2. 5.1.1 Global Clotting Factors Ⅷ Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Clotting Factors Ⅷ Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Clotting Factors Ⅷ Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Clotting Factors Ⅷ Sales by Type
  6. 5.2.1 Global Clotting Factors Ⅷ Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Clotting Factors Ⅷ Sales by Type (2021-2032) & (k units)
  8. 5.2.3 Global Clotting Factors Ⅷ Sales Market Share by Type (2021-2032)
  9. 5.3 Global Clotting Factors Ⅷ Price by Type
6 Clotting Factors Ⅷ Market by Application
  1. 6.1 Global Clotting Factors Ⅷ Revenue by Application
  2. 6.1.1 Global Clotting Factors Ⅷ Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Clotting Factors Ⅷ Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Clotting Factors Ⅷ Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Clotting Factors Ⅷ Sales by Application
  6. 6.2.1 Global Clotting Factors Ⅷ Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Clotting Factors Ⅷ Sales by Application (2021-2032) & (k units)
  8. 6.2.3 Global Clotting Factors Ⅷ Sales Market Share by Application (2021-2032)
  9. 6.3 Global Clotting Factors Ⅷ Price by Application
7 Company Profiles
  1. 7.1 Taibang Biological
  2. 7.1.1 Taibang Biological Company Information
  3. 7.1.2 Taibang Biological Business Overview
  4. 7.1.3 Taibang Biological Clotting Factors Ⅷ Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Taibang Biological Clotting Factors Ⅷ Product Portfolio
  6. 7.1.5 Taibang Biological Recent Developments
  7. 7.2 Shanghai Laishi
  8. 7.2.1 Shanghai Laishi Company Information
  9. 7.2.2 Shanghai Laishi Business Overview
  10. 7.2.3 Shanghai Laishi Clotting Factors Ⅷ Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Shanghai Laishi Clotting Factors Ⅷ Product Portfolio
  12. 7.2.5 Shanghai Laishi Recent Developments
  13. 7.3 Lvshizi
  14. 7.3.1 Lvshizi Company Information
  15. 7.3.2 Lvshizi Business Overview
  16. 7.3.3 Lvshizi Clotting Factors Ⅷ Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Lvshizi Clotting Factors Ⅷ Product Portfolio
  18. 7.3.5 Lvshizi Recent Developments
  19. 7.4 Hualan Biological
  20. 7.4.1 Hualan Biological Company Information
  21. 7.4.2 Hualan Biological Business Overview
  22. 7.4.3 Hualan Biological Clotting Factors Ⅷ Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Hualan Biological Clotting Factors Ⅷ Product Portfolio
  24. 7.4.5 Hualan Biological Recent Developments
8 North America
  1. 8.1 North America Clotting Factors Ⅷ Market Size by Type
  2. 8.1.1 North America Clotting Factors Ⅷ Revenue by Type (2021-2032)
  3. 8.1.2 North America Clotting Factors Ⅷ Sales by Type (2021-2032)
  4. 8.1.3 North America Clotting Factors Ⅷ Price by Type (2021-2032)
  5. 8.2 North America Clotting Factors Ⅷ Market Size by Application
  6. 8.2.1 North America Clotting Factors Ⅷ Revenue by Application (2021-2032)
  7. 8.2.2 North America Clotting Factors Ⅷ Sales by Application (2021-2032)
  8. 8.2.3 North America Clotting Factors Ⅷ Price by Application (2021-2032)
  9. 8.3 North America Clotting Factors Ⅷ Market Size by Country
  10. 8.3.1 North America Clotting Factors Ⅷ Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Clotting Factors Ⅷ Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Clotting Factors Ⅷ Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Clotting Factors Ⅷ Market Size by Type
  2. 9.1.1 Europe Clotting Factors Ⅷ Revenue by Type (2021-2032)
  3. 9.1.2 Europe Clotting Factors Ⅷ Sales by Type (2021-2032)
  4. 9.1.3 Europe Clotting Factors Ⅷ Price by Type (2021-2032)
  5. 9.2 Europe Clotting Factors Ⅷ Market Size by Application
  6. 9.2.1 Europe Clotting Factors Ⅷ Revenue by Application (2021-2032)
  7. 9.2.2 Europe Clotting Factors Ⅷ Sales by Application (2021-2032)
  8. 9.2.3 Europe Clotting Factors Ⅷ Price by Application (2021-2032)
  9. 9.3 Europe Clotting Factors Ⅷ Market Size by Country
  10. 9.3.1 Europe Clotting Factors Ⅷ Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Clotting Factors Ⅷ Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Clotting Factors Ⅷ Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Clotting Factors Ⅷ Market Size by Type
  2. 10.1.1 China Clotting Factors Ⅷ Revenue by Type (2021-2032)
  3. 10.1.2 China Clotting Factors Ⅷ Sales by Type (2021-2032)
  4. 10.1.3 China Clotting Factors Ⅷ Price by Type (2021-2032)
  5. 10.2 China Clotting Factors Ⅷ Market Size by Application
  6. 10.2.1 China Clotting Factors Ⅷ Revenue by Application (2021-2032)
  7. 10.2.2 China Clotting Factors Ⅷ Sales by Application (2021-2032)
  8. 10.2.3 China Clotting Factors Ⅷ Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Clotting Factors Ⅷ Market Size by Type
  2. 11.1.1 Asia Clotting Factors Ⅷ Revenue by Type (2021-2032)
  3. 11.1.2 Asia Clotting Factors Ⅷ Sales by Type (2021-2032)
  4. 11.1.3 Asia Clotting Factors Ⅷ Price by Type (2021-2032)
  5. 11.2 Asia Clotting Factors Ⅷ Market Size by Application
  6. 11.2.1 Asia Clotting Factors Ⅷ Revenue by Application (2021-2032)
  7. 11.2.2 Asia Clotting Factors Ⅷ Sales by Application (2021-2032)
  8. 11.2.3 Asia Clotting Factors Ⅷ Price by Application (2021-2032)
  9. 11.3 Asia Clotting Factors Ⅷ Market Size by Country
  10. 11.3.1 Asia Clotting Factors Ⅷ Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Clotting Factors Ⅷ Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Clotting Factors Ⅷ Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Clotting Factors Ⅷ Market Size by Type
  2. 12.1.1 SAMEA Clotting Factors Ⅷ Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Clotting Factors Ⅷ Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Clotting Factors Ⅷ Price by Type (2021-2032)
  5. 12.2 SAMEA Clotting Factors Ⅷ Market Size by Application
  6. 12.2.1 SAMEA Clotting Factors Ⅷ Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Clotting Factors Ⅷ Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Clotting Factors Ⅷ Price by Application (2021-2032)
  9. 12.3 SAMEA Clotting Factors Ⅷ Market Size by Country
  10. 12.3.1 SAMEA Clotting Factors Ⅷ Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Clotting Factors Ⅷ Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Clotting Factors Ⅷ Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Clotting Factors Ⅷ Value Chain Analysis
  2. 13.1.1 Clotting Factors Ⅷ Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Clotting Factors Ⅷ Production Mode & Process
  6. 13.2 Clotting Factors Ⅷ Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Clotting Factors Ⅷ Distributors
  9. 13.2.3 Clotting Factors Ⅷ Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst